Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trialsThe Lancet (British edition), 2022-02, Vol.399 (10326), p.741-755 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00018-6 ;PMID: 35085503Full text available |
|
2 |
Material Type: Article
|
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular EdemaAmerican journal of ophthalmology, 2022-06, Vol.238, p.157-172 [Peer Reviewed Journal]2022 ;Copyright © 2022. Published by Elsevier Inc. ;Copyright Elsevier Limited Jun 2022 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2022.01.004 ;PMID: 35038415Full text available |
|
3 |
Material Type: Article
|
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular EdemaThe New England journal of medicine, 2015-03, Vol.372 (13), p.1193-1203 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;Copyright © 2015 Massachusetts Medical Society. 2015 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1414264 ;PMID: 25692915Full text available |
|
4 |
Material Type: Article
|
Pharmacology of Corticosteroids for Diabetic Macular EdemaInvestigative ophthalmology & visual science, 2018-01, Vol.59 (1), p.1-12 [Peer Reviewed Journal]Copyright 2018 The Authors 2018 ;ISSN: 1552-5783 ;ISSN: 0146-0404 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.17-22259 ;PMID: 29297055Full text available |
|
5 |
Material Type: Article
|
Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot StudyAmerican journal of ophthalmology, 2015-07, Vol.160 (1), p.35-44.e1 [Peer Reviewed Journal]Elsevier Inc. ;2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 2015 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2015.04.021 ;PMID: 25896459 ;CODEN: AJOPAAFull text available |
|
6 |
Material Type: Article
|
Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical TrialArchives of ophthalmology (1960), 2021-07, Vol.139 (7), p.701 [Peer Reviewed Journal]Copyright American Medical Association Jul 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2021.0606Full text available |
|
7 |
Material Type: Article
|
Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I DataAmerican journal of ophthalmology, 2016-12, Vol.172, p.72-79 [Peer Reviewed Journal]2016 The Authors ;Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 01, 2016 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2016.09.012 ;PMID: 27644589 ;CODEN: AJOPAAFull text available |
|
8 |
Material Type: Article
|
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupEye (London), 2020-06, Vol.34 (Suppl 1), p.1-51 [Peer Reviewed Journal]The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2020. ;The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2020 ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/s41433-020-0961-6 ;PMID: 32504038Full text available |
|
9 |
Material Type: Article
|
VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathyAnnals of medicine (Helsinki), 2022-12, Vol.54 (1), p.1089-1111 [Peer Reviewed Journal]2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2022.2064541 ;PMID: 35451900Full text available |
|
10 |
Material Type: Article
|
Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic RetinopathyOxidative medicine and cellular longevity, 2017-01, Vol.2017, p.9702820-15 [Peer Reviewed Journal]Copyright © 2017 Cheng Li et al. ;Copyright © 2017 Cheng Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2017 Cheng Li et al. 2017 ;ISSN: 1942-0900 ;EISSN: 1942-0994 ;DOI: 10.1155/2017/9702820 ;PMID: 28265339Full text available |
|
11 |
Material Type: Article
|
How to prevent the microvascular complications of type 2 diabetes beyond glucose controlBMJ (Online), 2017-01, Vol.356 (8091), p.i6505-i6505 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i6505 ;PMID: 28096078Full text available |
|
12 |
Material Type: Article
|
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyesBritish journal of ophthalmology, 2021-02, Vol.105 (2), p.216-221 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-315933 ;PMID: 32265201Full text available |
|
13 |
Material Type: Article
|
Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic RetinopathyInvestigative ophthalmology & visual science, 2020-02, Vol.61 (2), p.26-26 [Peer Reviewed Journal]Copyright 2020 The Authors 2020 ;ISSN: 1552-5783 ;ISSN: 0146-0404 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.61.2.26 ;PMID: 32084272Full text available |
|
14 |
Material Type: Article
|
Retinal ganglion cells in diabetesThe Journal of physiology, 2008-09, Vol.586 (18), p.4401-4408 [Peer Reviewed Journal]2008 The Authors. Journal compilation © 2008 The Physiological Society ;2008 The Authors. Journal compilation © 2008 The Physiological Society 2008 ;ISSN: 0022-3751 ;EISSN: 1469-7793 ;DOI: 10.1113/jphysiol.2008.156695 ;PMID: 18565995Full text available |
|
15 |
Material Type: Article
|
Association of Ultra-Widefield Fluorescein Angiography–Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over TimeArchives of ophthalmology (1960), 2022-10, Vol.140 (10), p.936 [Peer Reviewed Journal]Copyright American Medical Association Oct 2022 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2022.3130Full text available |
|
16 |
Material Type: Article
|
A review of anti-VEGF agents for proliferative diabetic retinopathyEye (London), 2014-05, Vol.28 (5), p.510-520 [Peer Reviewed Journal]Copyright Nature Publishing Group May 2014 ;Copyright © 2014 Royal College of Ophthalmologists 2014 Royal College of Ophthalmologists ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/eye.2014.13 ;PMID: 24525867Full text available |
|
17 |
Material Type: Article
|
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II studyDiabetes care, 2010-11, Vol.33 (11), p.2399-2405 [Peer Reviewed Journal]2015 INIST-CNRS ;COPYRIGHT 2010 American Diabetes Association ;Copyright American Diabetes Association Nov 2010 ;2010 by the American Diabetes Association. ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc10-0493 ;PMID: 20980427 ;CODEN: DICAD2Full text available |
|
18 |
Material Type: Article
|
Association of Statin Therapy With Prevention of Vision-Threatening Diabetic RetinopathyArchives of ophthalmology (1960), 2019-04, Vol.137 (4), p.363 [Peer Reviewed Journal]Copyright American Medical Association Apr 2019 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2018.6399Full text available |
|
19 |
Material Type: Article
|
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathyProceedings of the National Academy of Sciences - PNAS, 2015-06, Vol.112 (23), p.E3030-E3039 [Peer Reviewed Journal]Volumes 1–89 and 106–112, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Jun 9, 2015 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1423765112 ;PMID: 26039997Full text available |
|
20 |
Material Type: Article
|
Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF TherapyAmerican journal of ophthalmology, 2022-03, Vol.235, p.80-89 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2021.09.002 ;PMID: 34509431Full text available |